FAIRFAX, Va. – The Inova Personalized Health Accelerator is accepting business plan applications from early stage health care technology firms with a focus on personalized health.
The IPHA provides C-suite coaches, customized plans, early stage capital, connections to strategic partners and later stage capital and connections to customers for health care technology and services entrepreneurs.
“This bespoke approach to enhance med-tech entrepreneurs’ efforts to accelerate new companies through the early stages of product design, capital formation and commercialization will serve as the foundation for a stronger health care ecosystem in the mid-Atlantic region,” said Kelly Schlageter, an Inova spokeswoman, in a statement.
Companies that qualify for the IHPA are pre-series A and/or seed stage companies with working prototypes of their technology who are seeking venture investment for product development and commercialization. The types of companies being sought include medical devices, diagnostics, digital health, sensor technologies, A.I./machine learning, genomics & precision medicine and software/analytics.
IPHA has a year-round, rolling application process, and will focus on a maximum of six companies at any time to provide individual attention.